Careers

Support

Liberty® Select with Kinexus®

Liberty® Select with Kinexus® allows providers to customize treatment options to meet patients’ clinical and lifestyle needs, address staff efficiency and grow home dialysis. By incorporating the Kinexus Remote Therapy Management platform, Liberty® Select aims to improve patient experience and outcomes on PD by offering simple, safe, and connected PD therapy.

REMOTE THERAPY MANAGEMENT WITH KINEXUS

Liberty Select transmits post treatment data to the center for remote therapy monitoring

Liberty Select patients receive adjusted therapy programs from center for remote therapy programming

Designed to reduce reliance on paper flow sheets

89% reduced risk of PD patient attrition in the first year when 5 or more prescription alterations are made1*

*Based on observational data collected as part of a study using the Liberty Modem

EASE OF USE AND TRAINING

User interface is designed to be intuitive with a large, color touchscreen for easier data entry

Step-by-step instructions guide the patient through setup, treatment, and troubleshooting

Color coded icons on screen match color coded clamps on cycler set

VERSATILE, PERSONALIZED PROGRAMMING

PD Plus™, a daytime exchange and cost-effective option that does not require a CAPD bag or additional cycler set

Treatment Based therapy for when treatment should be delivered within a certain time

Cycle Based therapy to ensure a prescribed dwell time is met

Flow alert options for fewer alarms and alerts at night

Customizable drain options & visibility to Total Ultrafiltration (UF)

STAY•SAFE PIN TECHNOLOGY

stay•safe PIN technology helps reduce the potential risk of touch contamination

UPGRADABLE OPERATING SYSTEM

Existing cyclers can be upgraded to enable remote therapy programming

Updates average less than 30 minutes

VISIT OUR PORTAL TO REPORT CYCLER UPGRADE STATUS

Looking for PD Training? Visit our Product Education Portal

VISIT NOW

Learn more about Liberty Select.

To learn more about Liberty Select, please fill out the form below. 

Explore Liberty Select with Kinexus

         

 RESOURCES

 

    RELATED PRODUCTS

 

stay•safe® CAPD System

ABOUT stay•safe / CAPD
Isolated flat screen with clipping path

 

Kinexus® Therapy Management Platform

 

ABOUT Kinexus

 

Reference:

  1. Parameswaran, V., Linda Ficociello, Mullon, C., Chatoth, D., Kraus, M., Giles, H., Anger, M., Alterations to Peritoneal Dialysis Prescriptions in the First 120 Days of Dialysis May Reduce the  Risk of Attrition [Abstract]. ASN 2021

Indications for Use: The Fresenius Liberty Select Cycler is indicated for acute and chronic peritoneal  dialysis.

Caution: Federal (U.S.) law restricts these devices to sale by or on the order of a physician.

Note: Read the Instructions for Use for safe and proper use of these devices. For a complete  description of hazards, contraindications, side effects, and precautions, see full package  labeling at www.fmcna.com.

Use: The Kinexus Portal is intended to allow clinicians to review patient data  collected during peritoneal dialysis therapy and to enable physicians to create peritoneal  dialysis therapy programs for the Liberty Select Cycler. The Kinexus portal does not provide  medical diagnoses or recommendations regarding medical treatment. The Kinexus Portal and  the content appearing on this site are not substitutes for professional medical advice,  diagnosis, or treatment.

Use: The Kinexus Gateway is intended for transmission of home dialysis therapy data and patient data for patients using certain Fresenius products, including peritoneal dialysis cycler(s).

Kinexus is not an electronic health record (EHR) or billing solution

Distributed by NxStage Medical, Inc., a subsidiary of Fresenius Medical Care.

© 2023 Fresenius Medical Care. All Rights Reserved. Fresenius Medical Care, the triangle logo, Kinexus, Liberty, Liberty Select, PD Plus, stay·safe and NxStage are trademarks of Fresenius Medical Care Holdings, Inc. or its affiliated companies. All other trademarks are the property of their respective owners.  P/N 103369-01 Rev J 06/2023